According to this study, many people who have current knowledge about Parkinson’s disease are not reflected by the diversity among the people who existed with the disease.
Parkinson’s Research Includes Equity, Inclusion, And Diversity
Michael J. Fox is the lead researcher and author of this study; he says that “the research team had defined about the action among the major area which is reduced into the advance treatments and health disparities for everyone.
On this note, the study highlights the steps in people with Parkinson’s disease and applies the foundation mark among some areas in the body. Here it must be noted that Parkinson’s is a disease with the fastest development rate worldwide, and hence experts try to find solutions that can help the patient in the early stage of this ailment. Different factors are being considered by them.
Researchers say that Parkinson’s disease symptoms are seen among millions of people across the United States and six times double across the world. These numbers are raised in the coming decades.
Based on the definitive shreds of evidence, real lack of incidence things has happened, including mortality and morbidity too, which is varied from the Parkinson’s disease between the ethnic groups and socioeconomic groups.
Bernadette Siddiqi is the lead researcher and author of this study; he says that this study is assembled relatively within the homogeneous population, and among the large data, the non-existent groups are represented among Latino, Asian, LGBTQ+, individuals among low socioeconomic status, Indigenous groups, and Black.
Siddiqi is the senior researcher and author of this study; he says that without the data, it is impossible to comprehend the depth, breadth, and length of Parkinson’s disease among the entire population.
The authors of this study noted that “poor representation is given from the research and looked incomplete based on the true diversity of the Parkinson’s disease.”
On this note, they say that minority clinical trials were conducted by reporting the ethnicity and race data on only 8 percent of the participants who are non-white.
Based on the accurate reflection, the people with Parkinson’s disease are at critical challenges with other factors and genetic variations through the specific endemic that could impact the risk of disease and effectiveness, metabolism of the respective drug.
Researcher Michael reported about four major areas which are taken for the activities such as:
- Identifying solutions and barriers.
- Finding research with greater inclusive participants.
- Building a workforce of the researcher by committing to health equity.
- Supports the understanding of holistic Parkinson’s disease
Based on the research about Parkinson’s disease, most of the applicants got promoted by the inclusions, and also many of the applicants were invited for submitting proposals that are focused mainly on the etiology, diagnostic challenges, underlying pathology, healthcare behavior, clinical presentation, disease burden, health outcomes, and incidence.
On this note, the researchers stated that “our understandings about the etiology findings are done through the growth factors in Parkinson’s disease with treatments and clinical presentations had remained the completeness.”
According to the clinical researches on Parkinson’s disease, research continues to represent the failure attempts whoa are associated with this disease.
Authors had commented that “biological underpinnings of the Parkinson’s disease are ensured about the treatments which work among the people with Parkinson’s disease.”
Based on the Parkinson’s disease research, some factors are driven into the disparities, which are included with complex and societal challenges. When the strategies are implemented, the process could be supported for creating health equity among people with Parkinson’s disease.
Investigators conclude that “when awareness is increased current state of research on Parkinson’s disease are also available along with the infrastructure and resources.”
